A549 cells were transfected with a NF-κB reporter plasmid, pNF–κB–Luc (A549–NF-κB–Luc cells) using BioT transfection kit (Bioland Scientific, Paramount, CA, USA). A549–NF-κB–Luc cells were grown to 70% confluence in a 96-well plate. Viral particles (MOI 1) were incubated with 20 µg/mL of C1q, ghA, ghB, ghC, or MBP for 1 h at room temperature and then for another h at 4 °C. The pre-treated viral particles were used to challenge the A549–NF-κB–Luc cells in infection media for 6 h. Virus particles that were not treated with C1q, or treated with MBP alone were used as control. A549–NF-κB–Luc cells treated with recombinant TNF-α (10 ng/ml) and IL-1β (10 ng/ml) (R&D Systems) were used as positive controls for NF-κB activation. Luminescence proportional to the NF-κB activity was measured in relative units using a Clariostar Plus Microplate Reader (BMG Labtech, Ortenberg, Germany).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.